ABG-WTT Global Life Science Capital Partners GP Ltd Long-Term Concentrated

Name: ABG-WTT Global Life Science Capital Partners GP Ltd Q2 2023 13F Filing | 13F Explorer
Creator: ABG-WTT Global Life Science Capital Partners GP Ltd
Published: 2023-08-14

Location: Central, Hong Kong, Hong Kong

CIK: 0001832108 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value: $5.511M (100.0% shares, 0.0% debt)

Holdings (3)

— MEDAVAIL HOLDINGS INC 66.8%

Value $3.684M Shares 15,029,480 Est. Cost $5.03 Unrealized —

RPID RAPID MICRO BIOSYSTEMS INC 18.8%

Value $1.038M Shares 1,038,296 Est. Cost $7.36 Unrealized -86.3%

LUNG PULMONX CORP 14.3%

Value $789K Shares 60,204 Est. Cost $48.97 Unrealized -75.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	MEDAVAIL HOLDINGS INC	15,029,480	$3.684M	66.8%	$5.03	—	COM	58406B103
RPID	RAPID MICRO BIOSYSTEMS INC	1,038,296	$1.038M	18.8%	$7.36	-86.3%	CLASS A COM	75340L104
LUNG	PULMONX CORP	60,204	$789K	14.3%	$48.97	-75.0%	COM	745848101